Blue Jet Healthcare Ltd.

512.5

14.1 (2.8%)stock indicator image for upward trend

As on June 12, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap8,893 Cr
P/E Ratio64.23
Dividend YieldN/A
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open501
High520.8
NSE SymbolBLUEJET
Close512.5
Low493.65
BSE Symbol544009
Previous Years High/Low
1 Year High1,027.8
3 Year High1,027.8
5 Year High1,027.8
1 Year Low325
3 Year Low319.5
5 Year Low319.5

Technicals


IndicatorsValueSignal
5-DMA479.89Bullish
10-DMA468.64Bullish
20-DMA459.71Bullish
50-DMA436.61Bullish
100-DMA417.81Bullish
200-DMA518.29Bearish

Historical Performance


1 Year
-46.8%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsMar-2021Mar-2020
Net Sales4,9895,382
Total Expenditure2,9293,245
Other Income8958
Operating Profit2,1492,195
Interest5374
Depreciation197180
Profit Before Tax1,8471,941
Consolidated Net Profit1,3841,448
Adjusted EPS8138
Compounded Sales Growth
10 Years:-1.5
5 Years:-1.5
3 Years:-1.5
TTM:-1.5
Compounded Profit Growth
10 Years:-0.9
5 Years:-0.9
3 Years:-0.9
TTM:-0.9
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:-46.3
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:8

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


ParticularsMar-2021Mar-2020
Share Capital996
Total Reserves3,2991,915
Long-Term Borrowings------
Total Non-Current Liabilities334379
Other Current Liabilities461586
Short Term Borrowings71178
Total Liabilities5,9324,317
Capital Work in Progress2620
Long Term Loans & Advances4774
Currents Investments368253
Short Term Loans and Advances738742
Total Current Assets4,4703,067
Total Assets5,9324,317
Adjusted Book Value20183
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 64.23, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a moderate 3-year price CAGR of 11.3%, reflecting average market performance.
  • The stock carries a high beta of 1.5, implying higher volatility and elevated risk.
  • In the last financial year, the company reported an EBITDA of ₹2149 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹4989 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 546055.1
No. of Shares: 1065 (Approx)
Performance:-45.4%
P/L: ₹-453944.9
NIFTY Performance: -4.4%
1 day Top Gainers
SymbolChange%
IFCI84.57(20%)
AIIL530.15(15%)
TTML46.44(10%)
ASHOKLEY152.45(10%)
NETWEB4587.4(9%)
1 Day Top Losers
SymbolChange%
NESTLEIND1375.7(-3%)
OIL417.8(-3%)
ONGC246.2(-3%)
TECHM1429.2(-3%)
ONESOURCE1612.5(-2%)
INOXINDIA1808.2(-2%)
PREMIERENE1034.6(-2%)
IPCALAB1583(-2%)

Top Performing Stocks from the same sector


Venus Remedies Ltd.

92.9%

1797.5

1 Month Performance

Bliss GVS Pharma Ltd.

59.9%

437.85

1 Month Performance

Panacea Biotec Ltd.

46.6%

536

1 Month Performance

Sakar Healthcare Ltd.

44.7%

824.1

1 Month Performance

Supriya Lifescience Ltd.

44.6%

977.15

1 Month Performance

Rubicon Research Ltd.

39.6%

1295.5

1 Month Performance

NGL Fine-Chem Ltd.

39.3%

3048.8

1 Month Performance

Senores Pharmaceuticals Ltd.

38.3%

1290

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month